Download PDF
Thorac Cardiovasc Surg 2015; 63(02): 120-125
DOI: 10.1055/s-0033-1357084
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Early and Long-Term Effect of Thoracic Endovascular Aortic Repair for Stanford B Aortic Dissection

Zhong-Bao Ruan
1   Department of Cardiology, Taizhou People's Hospital, Taizhou, People's Republic of China
,
Li Zhu
1   Department of Cardiology, Taizhou People's Hospital, Taizhou, People's Republic of China
,
Ge-Cai Chen
1   Department of Cardiology, Taizhou People's Hospital, Taizhou, People's Republic of China
,
Yi-Gang Yin
1   Department of Cardiology, Taizhou People's Hospital, Taizhou, People's Republic of China
› Author Affiliations
Further Information

Publication History

26 June 2013

20 August 2013

Publication Date:
14 October 2013 (online)

    Permissions and Reprints All articles of this category

Abstract

Background Uncomplicated Stanford B acute aortic dissection (AAD) is generally treated with medical management; whereas complicated dissections require surgery or thoracic endovascular aortic repair (TEVAR). Studies have demonstrated that long-term outcomes with medical management are suboptimal. Therefore, we sought to investigate the early and long-term clinical efficacy of TEVAR for Stanford B AAD.

Materials and Methods From March 2004 to January 2008, 63 consecutive patients were treated and retrospectively placed into either one of the two groups, the TEVAR group (n = 42) and the medicine group (n = 21). All TEVAR procedures were performed in the acute phase. The changes of true and false lumen diameter were monitored with computed tomography angiography examinations in the thoracic aorta at the level of the stented segment at long-term follow-up.

Results As compared with the medicine group, the age at intervention in the TEVAR group was higher (p < 0.05), and they also had more patent false lumen in this group. Patients in the TEVAR group had significantly longer hospital stays than those in the medicine group (p < 0.01). The incidence of the early events was not significantly different between the two groups. The incidence of aortic-related late events and late death were significantly higher in the medicine group than those in the TEVAR group. Log-rank tests demonstrated that patients treated with medical management had significantly more late adverse events than did those treated with TEVAR (p < 0.01). At 1-year follow-up, the true lumen diameter in the thoracic aorta at the level of the stented segment increased significantly after TEVAR, and the mean reduction of false lumen diameter was highly significant. The remodeling was stable at 3 and 5 years after TEVAR.

Conclusion Patients with Stanford B AAD treated with TEVAR experienced fewer late adverse events than those treated with medical management, TEVAR could be an effective treatment for Stanford B AAD.

Keywords

aortic dissection - Stanford B - thoracic endovascular aortic repair - early events - late events
 

  • References

  • 1 Suzuki S, Masuda M. An update on surgery for acute type A aortic dissection: aortic root repair, endovascular stent graft, and genetic research. Surg Today 2009; 39 (4) 281-289
    CrossrefPubMedGoogle Scholar
  • 2 Goda M, Imoto K, Suzuki S , et al. Risk analysis for hospital mortality in patients with acute type a aortic dissection. Ann Thorac Surg 2010; 90 (4) 1246-1250
    CrossrefPubMedGoogle Scholar
  • 3 Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994; 331 (26) 1729-1734
    CrossrefPubMedGoogle Scholar
  • 4 De Rango P, Estrera A. Uncomplicated type B dissection: are there any indications for early intervention?. J Cardiovasc Surg (Torino) 2011; 52 (4) 519-528
    PubMedGoogle Scholar
  • 5 Criado FJ. Aortic dissection: a 250-year perspective. Tex Heart Inst J 2011; 38 (6) 694-700
    PubMedGoogle Scholar
  • 6 Fattori R, Tsai TT, Myrmel T , et al. Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv 2008; 1 (4) 395-402
    CrossrefPubMedGoogle Scholar
  • 7 Trimarchi S, Eagle KA, Nienaber CA , et al; International Registry of Acute Aortic Dissection (IRAD) Investigators. Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2010; 122 (13) 1283-1289
    CrossrefPubMedGoogle Scholar
  • 8 Nienaber CA, Rousseau H, Eggebrecht H , et al; INSTEAD Trial. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt grafts in Aortic Dissection (INSTEAD) trial. Circulation 2009; 120 (25) 2519-2528
    CrossrefPubMedGoogle Scholar
  • 9 O'Donnell S, Geotchues A, Beavers F , et al. Endovascular management of acute aortic dissections. J Vasc Surg 2011; 54 (5) 1283-1289
    CrossrefPubMedGoogle Scholar
  • 10 Steuer J, Eriksson MO, Nyman R, Björck M, Wanhainen A. Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection. Eur J Vasc Endovasc Surg 2011; 41 (3) 318-323
    CrossrefPubMedGoogle Scholar
  • 11 Svensson LG, Kouchoukos NT, Miller DC , et al; Society of Thoracic Surgeons Endovascular Surgery Task Force. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg 2008; 85 (1, Suppl): S1-S41
    CrossrefPubMedGoogle Scholar
  • 12 De Rango P, Estrera A. Uncomplicated type B dissection: are there any indications for early intervention?. J Cardiovasc Surg (Torino) 2011; 52 (4) 519-528
    PubMedGoogle Scholar
  • 13 Zeeshan A, Woo EY, Bavaria JE , et al. Thoracic endovascular aortic repair for acute complicated type B aortic dissection: superiority relative to conventional open surgical and medical therapy. J Thorac Cardiovasc Surg 2010; 140 (6, Suppl): S109-S115 , discussion S142–S146
    CrossrefPubMedGoogle Scholar
  • 14 Ehrlich MP, Dumfarth J, Schoder M , et al. Midterm results after endovascular treatment of acute, complicated type B aortic dissection. Ann Thorac Surg 2010; 90 (5) 1444-1448
    CrossrefPubMedGoogle Scholar
  • 15 Hagan PG, Nienaber CA, Isselbacher EM , et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000; 283 (7) 897-903
    CrossrefPubMedGoogle Scholar
  • 16 Dialetto G, Covino FE, Scognamiglio G , et al. Treatment of type B aortic dissection: endoluminal repair or conventional medical therapy?. Eur J Cardiothorac Surg 2005; 27 (5) 826-830
    CrossrefPubMedGoogle Scholar
  • 17 Xu SD, Huang FJ, Yang JF , et al. Early and midterm results of thoracic endovascular aortic repair of chronic type B aortic dissection. J Thorac Cardiovasc Surg 2010; 139 (6) 1548-1553
    CrossrefPubMedGoogle Scholar
  • 18 Conrad MF, Crawford RS, Kwolek CJ, Brewster DC, Brady TJ, Cambria RP. Aortic remodeling after endovascular repair of acute complicated type B aortic dissection. J Vasc Surg 2009; 50 (3) 510-517
    CrossrefPubMedGoogle Scholar
  • 19 Kitai T, Kaji S, Yamamuro A , et al. Impact of new development of ulcer-like projection on clinical outcomes in patients with type B aortic dissection with closed and thrombosed false lumen. Circulation 2010; 122 (11, Suppl): S74-S80
    CrossrefPubMedGoogle Scholar
  • 20 Fioranelli A, Razuk Filho A, Castelli Júnior V, Karakhanian W, Godoy JM, Caffaro RA. Mortality within the endovascular treatment in Stanford type B aortic dissections. Rev Bras Cir Cardiovasc 2011; 26 (2) 250-257
    CrossrefPubMedGoogle Scholar